Cargando…
Treatment of Fanconi anemia patients using fludarabine and low-dose total body irradiation followed by unrelated donor hematopoietic cell transplantation
A non-myeloablative conditioning regimen consisting of fludarabine (FLU) and 2 Gy total body irradiation (TBI) has been used with great experience and engraftment success without promoting excessive non-relapse mortality (NRM) in medically infirm patients requiring hematopoietic cell transplantation...
Autores principales: | Thakar, Monica S, Kurre, Peter, Storb, Rainer, Kletzel, Morris, Frangoul, Haydar, Pulsipher, Michael A., Leisenring, Wendy, Flowers, Mary Evelyn D, Sandmaier, Brenda M, Woolfrey, Ann, Kiem, Hans-Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2976796/ https://www.ncbi.nlm.nih.gov/pubmed/20581880 http://dx.doi.org/10.1038/bmt.2010.154 |
Ejemplares similares
-
Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia
por: Thakar, Monica S., et al.
Publicado: (2017) -
Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GVHD?
por: Gallo, Susanna, et al.
Publicado: (2016) -
Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
por: Mohanan, E, et al.
Publicado: (2017) -
Correction: Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
por: Mohanan, E., et al.
Publicado: (2018) -
Novel lineage depletion preserves autologous blood stem cells for
gene therapy of Fanconi anemia complementation group A
por: Adair, Jennifer E., et al.
Publicado: (2018)